| Literature DB >> 32595252 |
Barbara Dawidowsky1, Branimir Cerovski1, Aleksandra Klobučar1, Krsto Dawidowsky1.
Abstract
The aim was to determine whether improvement of near point of convergence (NPC) and binocular vision after orthoptic exercises had any impact on children and adolescents diagnosed with attention deficit/hyperactivity disorder (ADHD) and convergence insufficiency (CI). In this clinical trial, 50 children and adolescents aged 6 to 18 years diagnosed with ADHD and CI received orthoptic therapy that included home-based exercises (pencil push-ups and stereograms) and office-based therapy on synoptophore. Binocular vision and NPC were measured before, during and after therapy. Study subjects showed significant improvement (p<0.05) in NPC and binocular vision after orthoptic exercises. We found statistically significant correlation between stereovision improvement (Lang I) and near point of convergence, suggesting that improvement of binocular function is possible in children with ADHD and CI. Our results showed that NPC enhancement improved stereovision in patients with ADHD. Since progress of binocular function has positive effect on near work and diminishes visual symptoms in children and adolescents with ADHD and CI, it might be reasonable to suppose that orthoptic therapy helps these children improve concentration as well. Further studies are needed to determine whether it might have positive impact on attention.Entities:
Keywords: Attention deficit disorder with hyperactivity; Ocular motility disorders; Vision, binocular
Mesh:
Year: 2019 PMID: 32595252 PMCID: PMC7314288 DOI: 10.20471/acc.2019.58.04.14
Source DB: PubMed Journal: Acta Clin Croat ISSN: 0353-9466 Impact factor: 0.780
Descriptive data on NPC, stereo tests (Lang I, Lang II, Titmus test) and synoptophore at first visit
| Variable | M (SD) | TR (min, max) |
|---|---|---|
| NPC | 11.16 (3.431) | 15 (4-19) |
| Lang I | 1.62 (0.878) | 3 (0-3) |
| Lang II | 2.04 (0.699) | 3 (0-3) |
| Titmus test | 2.24 (0.797) | 3 (0-3) |
| Synoptophore | 11.14 (6.395) | 32 (0-32) |
NPC = near point of convergence measured in centimeters; Lang I and II = measures ability to see 0/3, 1/3, 2/3 or 3/3 figures; Titmus test = measures ability to see 0/3, 1/3, 2/3 or 3/3 figures; synoptophore = measures fusion span in degrees; TR = total range; M = mean; SD = standard deviation
Descriptive data on NPC, stereo tests (Lang I, Lang II, Titmus test) and synoptophore at second visit
| Variable | M (SD) | TR (min, max) |
|---|---|---|
| NPC | 6.32 (2.817) | 11 (3-14) |
| Lang I | 2.60 (0.639) | 2 (1-3) |
| Lang II | 2.72 (0.497) | 2 (1-3) |
| Titmus test | 2.88 (0.385) | 2 (1-3) |
| Synoptophore | 16.98 (6.523) | 29 (5-34) |
NPC = near point of convergence measured in centimeters; Lang I and II = measures ability to see 0/3, 1/3, 2/3 or 3/3 figures; Titmus test = measures ability to see 0/3, 1/3, 2/3 or 3/3 figures; synoptophore = measures fusion span in degrees; TR = total range; M = mean; SD = standard deviation
Descriptive data on NPC, stereo tests (Lang I, Lang II, Titmus test) and synoptophore at third visit
| Variable | M (SD) | TR (min, max) |
|---|---|---|
| NPC | 5.10 (1.961) | 7 (3-10) |
| Lang I | 2.80 (0.606) | 3 (0-3) |
| Lang II | 2.88 (0.520) | 3 (0-3) |
| Titmus test | 2.88 (0.480) | 2 (1-3) |
| Synoptophore | 17.88 (7.542) | 34 (4-38) |
NPC = near point of convergence (measured in centimeters); Lang I and II = measure ability to see 0/3, 1/3, 2/3 or 3/3 figures; Titmus test = measures ability to see 0/3, 1/3, 2/3 or 3/3 figures; synoptophore = measures fusion span in degrees; TR = total range; M = mean; SD = standard deviation
ANOVA of three repeated convergence measurements
| Measurement | Measurement | Standard deviation | Mean difference | Level of significance |
|---|---|---|---|---|
| 1 | 2 | 0.388 | 4.84* | 0.000 |
| 3 | 0.421 | 6.06* | 0.000 | |
| 2 | 1 | 0.388 | -4.84* | 0.000 |
| 3 | 0.289 | 1.22* | 0.000 | |
| 3 | 1 | 0.421 | -6.06* | 0.000 |
| 2 | 0.289 | -1.22* | 0.000 |
*p<0.05
ANOVA of three repeated Lang I stereo test measurements
| Measurement | Measurement | Standard deviation | Mean difference | Level of significance |
|---|---|---|---|---|
| 1 | 2 | 0.116 | -0.98* | 0.000 |
| 3 | 0.117 | -1.18* | 0.000 | |
| 2 | 1 | 0.116 | 0.98* | 0.000 |
| 3 | 0.081 | -0.20 | 0.051 | |
| 3 | 1 | 0.117 | 1.18* | 0.000 |
| 2 | 0.081 | 0.20 | 0.051 |
*p<0.05
ANOVA of three repeated Lang II stereo test measurements
| Measurement | Measurement | Standard deviation | Mean difference | Level of significance |
|---|---|---|---|---|
| 1 | 2 | 0.105 | -0.68* | 0.000 |
| 3 | 0.096 | -0.84* | 0.000 | |
| 2 | 1 | 0.105 | 0.68* | 0.000 |
| 3 | 0.072 | -0.16 | 0.093 | |
| 3 | 1 | 0.096 | 0.84* | 0.000 |
| 2 | 0.072 | 0.16 | 0.093 |
*p<0.05
Fig. 1Lang I test: number of patients seeing 0, 1, 2 or 3 figures. 0/3=sees no figure; 1/3=sees one figure; 2/3=sees two figures; 3/3=sees three figures
Fig. 2Lang II test: number of patients seeing 0, 1, 2 or 3 figures. 0/3=sees no figure; 1/3=sees one figure; 2/3=sees two figures; 3/3=sees three figures
ANOVA of three repeated Titmus ABC measurements
| Measurement | Measurement | Standard deviation | Mean difference | Level of significance |
|---|---|---|---|---|
| 1 | 2 | 0.120 | -0.64* | 0.000 |
| 3 | 0.127 | -0.64* | 0.000 | |
| 2 | 1 | 0.120 | 0.64* | 0.000 |
| 3 | 0.057 | 0.00 | 1.000 | |
| 3 | 1 | 0.127 | 0.64* | 0.000 |
| 2 | 0.057 | 0.00 | 1.000 |
*p<0.05
ANOVA of three repeated synoptophore measurements
| Measurement | Measurement | Standard deviation | Mean difference | Level of significance |
|---|---|---|---|---|
| 1 | 2 | 0.884 | -5.84* | 0.000 |
| 3 | 1.062 | -6.74* | 0.000 | |
| 2 | 1 | 0.884 | 5.84* | 0.000 |
| 3 | 0.682 | -0.90 | 0.580 | |
| 3 | 1 | 1.062 | 6.74* | 0.000 |
| 2 | 0.682 | 0.90 | 0.580 |
*p<0.05
Fig. 3Near point of convergence, Lang I, Lang II, Titmus test and fusion span on synoptophore (SY) before and after orthoptic therapy (measurements 1, 2 and 3).
Fig. 4Near point of convergence before therapy, and three and six months after therapy.